Chronic kidney disease in india challenges and solutions

It appears that even in India diabetes and hypertension are responsible for 40 to 50 of all cases of chronic renal failure. The chronic diseases account for 60 of all deaths worldwide.

Chronic diseases have become a major public health problem.

Chronic kidney disease in india challenges and solutions. The burden of chronic kidney disease CKD in India cannot be assessed accurately. The approximate prevalence of CKD is 800 per million population pmp and the incidence of end-stage renal disease ESRD is 150-200 pmp. The most common cause of CKD in population-based studies is diabetic nephropathy.

India currently has 820 nephrologists 710. Thus taken together nearly 18000-20000 patients 10 of new ESRD cases in India get renal replacement therapy. The cost of single hemodialysis varies between USD 15 and 40 with an additional.

The true burden of ESKD in India is not known with few dedicated centers for care lack of universal access to RRT and absence of a registry. Even today over 90 of patients requiring RRT in India die because of inability to afford care and even in those who do start RRT 60 stop for financial reasons. Chronic diseases have become a major public health problem.

Chronic diseases are a leading cause of morbidity and mortality in India and other low-and middle-income countries. The chronic diseases account for 60 of all deaths worldwide. Basis is the only practical solution for India.

It appears that even in India diabetes and hypertension are responsible for 40 to 50 of all cases of chronic renal failure. Screening for these 2 diseases and CKD is simple and easy to perform. The best approach will be to start screening for CKD.

Chronic kidney disease CKD is an important chronic noncommunicable disease epidemic that affects the world including India. Because of the absence of a renal registry in India the true magnitude of CKDend-stage renal disease ESRD is unknown. Two community-based studies although methodologically different have shown a prevalence of chronic renal failure of 016 and.

Agarwal SK Srivastava RK. Nephron Clin Pract 2009111c197-203. Bagchi S Agarwal SK Gupta S.

Targeted screening of adult first-degree relatives for chronic kidney disease and its risk factors. Nephron Clin Prac 2010116c128-36. New Delhi Call for Action on combating Noncommunicable Diseases in Inida.

Key action points include the implementation of. 1 Chronic kidney disease CKD screening and prevention programs. 2 ESRD and transplantation registries.

3 transplantation legislation covering both living and deceased organ donation. 4 international and regional collaborations for transfer of knowledge and technology. Chronic kidney disease CKD has not received the same attention as other chronic diseases such as congestive heart failure.

Yet the prevalence and costs of CKD are substantial. Greater recognition and support for CKD may require that the disease no longer be viewed as one continuous disease. Chronic kidney diseases CKD causes at least 24 million deaths per year and are now the 6th fastest growing cause of deathThe social psychological and emotional effects of chronic kidney diseases CKDremain significant because of the challenges they pose on patients and their familiesHere we briefly discuss the various areas associated with kidney failure and the best ways to.

Chronic Kidney Disease Challenges and New Solutions 1. Chronic Kidney Disease CKD Challenges and New Solutions PREVALENCE OF CKD ACROSS THE US CKD MORBIDITYMORTALITY Estimated prevalence CKD US. Population 2015-2030 132 144 167 Current CKD Prevalence for Age 65 yo 44 SOURCES.

Hoerger TJ et al American Journal of Kidney Diseases. In India one in ten people has some form of chronic kidney disease. Diabetes and hypertension are responsible for more than 60 per cent cases of chronic kidney disease.

Other causes include glomerular diseases famililial renal disease like polycystic kidney disease immuniological diseases kidney stones urinary tract obstruction and drug. Chronic kidney disease CKD leads to progressive decline in glomerular filtration rate leading to electrolyte and metabolic imbalance 1 Prevalence of stage 3 and above CKD in Indians is found to. Chronic kidney disease in India.

Pravin Surendran 1 Vinayagamoorthy Venugopal 1 Amol R Dongre 1 Ravikumar Paninjukunnath 2. Large observational studies have shown a graded association between levels of serum phosphate and all-cause mortality in patients undergoing dialysis 711. Given these observations one of the principal challenges in the management of patients in the advanced stages of CKD is control of hyperphosphataemia.

We thank Zijin Chen and colleagues for their letter discussing the incidence and prevalence trends in end-stage kidney disease ESKD in Shanghai China between 2007 and 2015. 1 Their analysis is based on a local registry system including all dialysis centers and updates a recently published review we referenced on the disease burden of chronic kidney disease in North and East Asia. Hyperphosphataemia is a clinical consequence of the advanced stages of chronic kidney disease CKD.

Considerable evidence points to a role of hyperphosphataemia in the pathogenesis of CKD-associated cardiovascular CV complications including vascular calcification and with increased all-cause and CV mortality. Challenges and Opportunities in Late-Stage Chronic Kidney Disease. Clinical Kidney Journal.

8154 Flanagan S Damery S Combes G. September 29 2017 The Effectiveness of Integrated Care Interventions in Improving Patient Quality of Life for Patients with Chronic Conditions. This range is nearly three times higher than the national prevalence of 172.

1 4 As of 2015 it was estimated that more than 4500 people had died from chronic kidney disease in the last ten years and around 34 000 people had kidney diseases in Uddanam.